Literature DB >> 17885238

Long-term follow-up of cerebral aneurysms after endovascular therapy prediction and outcome of retreatment.

T Ries1, S Siemonsen, G Thomalla, U Grzyska, H Zeumer, J Fiehler.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of this study was to analyze angiographic and clinical results before and after additional endovascular therapy in patients with previously coiled but reopened cerebral aneurysms and to identify possible risk factors for retreatment of an aneurysm.
MATERIALS AND METHODS: Follow-up with selective digital subtraction angiography was performed in 323/596 (54.2%) patients harboring 342 aneurysms with a mean follow-up time of 28.6 months. The patients were divided into 3 groups: group A, who remained stable after initial treatment; group B, who showed minor morphologic changes; and group C, who underwent repeat treatment. Univariate and multivariate regression analyses were performed to determine possible risk factors for aneurysmal retreatment.
RESULTS: Single or multiple retreatment was performed in 33 of 323 (10.2%) patients. Retreatment of small aneurysms (< or =10 mm) with small necks (< or =4 mm) was performed in 6 of 214 aneurysms. When summarizing all other aneurysms as a "risk group" (n = 128), the odds ratio (OR) for retreatment in the "risk group" was 3.11 (95% CI: 1.43-6.75; P = .004). In patients with residual aneurysm after the first treatment, OR for retreatment was 3.96 (95% CI: 1.48-10.65; P = .006), whereas a neck remnant, clinical presentation, and aneurysmal localization were not predictive. We observed no resulting morbidity and mortality from the 33 retreatment procedures.
CONCLUSION: In our series, the retreatment of aneurysmal recurrences was a safe procedure. The best single predictors of aneurysmal recurrence were aneurysmal anatomy (neck width >4 mm and diameter >10 mm) and the presence of a residual aneurysm after initial treatment. A limitation in our study was the significant number of patients lost to follow-up (22.7%).

Entities:  

Mesh:

Year:  2007        PMID: 17885238      PMCID: PMC8134224          DOI: 10.3174/ajnr.A0649

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  35 in total

1.  Questionable interpretation of results of ACTIVE study on Matrix coils by Boston Scientific.

Authors:  Menno Sluzewski; Willem Jan van Rooij
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

2.  Rates of delayed rebleeding from intracranial aneurysms are low after surgical and endovascular treatment.

Authors: 
Journal:  Stroke       Date:  2006-04-20       Impact factor: 7.914

3.  Development of a biologically active Guglielmi detachable coil for the treatment of cerebral aneurysms. Part I: in vitro study.

Authors:  Y Murayama; Y Suzuki; F Viñuela; M Kaibara; K Kurotobi; M Iwaki; T Abe
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

4.  MR angiography at 3T versus digital subtraction angiography in the follow-up of intracranial aneurysms treated with detachable coils.

Authors:  Charles B L M Majoie; Marieke E Sprengers; Willem Jan J van Rooij; Cristina Lavini; Menno Sluzewski; Jeroen C van Rijn; Gerard J den Heeten
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

5.  Aneurysm recurrence after treatment of paraclinoid/ophthalmic segment aneurysms--a treatment-modality assessment.

Authors:  R Boet; G K C Wong; W S Poon; J M K Lam; S C H Yu
Journal:  Acta Neurochir (Wien)       Date:  2005-06       Impact factor: 2.216

6.  Rupture of intracranial aneurysms during treatment with Guglielmi detachable coils: incidence, outcome, and risk factors.

Authors:  M Sluzewski; J A Bosch; W J van Rooij; P C Nijssen; D Wijnalda
Journal:  J Neurosurg       Date:  2001-02       Impact factor: 5.115

7.  Natural history of the neck remnant of a cerebral aneurysm treated with the Guglielmi detachable coil system.

Authors:  M Hayakawa; Y Murayama; G R Duckwiler; Y P Gobin; G Guglielmi; F Viñuela
Journal:  J Neurosurg       Date:  2000-10       Impact factor: 5.115

8.  Matrix and bioabsorbable polymeric coils accelerate healing of intracranial aneurysms: long-term experimental study.

Authors:  Yuichi Murayama; Satoshi Tateshima; Nestor R Gonzalez; Fernando Vinuela
Journal:  Stroke       Date:  2003-07-17       Impact factor: 7.914

9.  Endovascular treatment of ruptured intracranial aneurysms with detachable coils: long-term clinical and serial angiographic results.

Authors:  Menno Sluzewski; Willem Jan van Rooij; Gabriël J E Rinkel; Douwe Wijnalda
Journal:  Radiology       Date:  2003-06       Impact factor: 11.105

10.  Detection and characterization of intracranial aneurysms with MR angiography: comparison of volume-rendering and maximum-intensity-projection algorithms.

Authors:  Ammar Mallouhi; Stephan Felber; Andreas Chemelli; Andreas Dessl; Alexandra Auer; Michael Schocke; Werner R Jaschke; Peter Waldenberger
Journal:  AJR Am J Roentgenol       Date:  2003-01       Impact factor: 3.959

View more
  58 in total

1.  Flow-diverter silk stent for the treatment of intracranial aneurysms: 1-year follow-up in a multicenter study.

Authors:  J Berge; A Biondi; P Machi; H Brunel; L Pierot; J Gabrillargues; K Kadziolka; X Barreau; V Dousset; A Bonafé
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

Review 2.  Endovascular treatment and radiographic follow-up of proximal traumatic intracranial aneurysms in adolescents: case series and review of the literature.

Authors:  Daniel H Fulkerson; Jason M Voorhies; Shannon P McCanna; Troy D Payner; Thomas J Leipzig; John A Scott; Andrew J DeNardo; Kathleen Redelman; Terry G Horner
Journal:  Childs Nerv Syst       Date:  2010-02-23       Impact factor: 1.475

3.  Long-term follow-up study of endovascularly treated intracranial aneurysms.

Authors:  L M Pyysalo; L H Keski-Nisula; T T Niskakangas; V J Kähärä; J E Ohman
Journal:  Interv Neuroradiol       Date:  2010-10-25       Impact factor: 1.610

Review 4.  "Coil mainly" policy in management of intracranial ACoA aneurysms: single-centre experience with the systematic review of literature and meta-analysis.

Authors:  Anna Steklacova; Ondrej Bradac; Patricia de Lacy; Jiri Lacman; Frantisek Charvat; Vladimir Benes
Journal:  Neurosurg Rev       Date:  2017-11-28       Impact factor: 3.042

5.  Endovascular treatment of recurrent coiled aneurysms: assessment of complications and rebleeding during a decade in a single center.

Authors:  J Sedat; Y Chau; K Moubarak; J Vargas; M Lonjon
Journal:  Interv Neuroradiol       Date:  2012-03-16       Impact factor: 1.610

6.  Five to ten years follow-up after coiling of 241 patients with acutely ruptured aneurysms. A single centre experience.

Authors:  A Consoli; L Renieri; R Mura; S Nappini; F Ricciardi; G Pecchioli; F Ammannati; S Mangiafico
Journal:  Interv Neuroradiol       Date:  2012-03-16       Impact factor: 1.610

7.  Using a covered stent for large cerebral aneurysms treated with stent-assisted coiling.

Authors:  Chun Fang; Chuan-Sen Liu; Ya-Ping Xiao; Mei Zhao; Jian-Min Zhang; Ming-Hua Li; Yue-Qi Zhu
Journal:  Interv Neuroradiol       Date:  2015-05-13       Impact factor: 1.610

8.  Stratification of recanalization for patients with endovascular treatment of intracranial aneurysms.

Authors:  Christopher S Ogilvy; Michelle H Chua; Matthew R Fusco; Arra S Reddy; Ajith J Thomas
Journal:  Neurosurgery       Date:  2015-04       Impact factor: 4.654

9.  Pipeline Embolization Device in the Treatment of Recurrent Previously Stented Cerebral Aneurysms.

Authors:  B Daou; R M Starke; N Chalouhi; S Tjoumakaris; D Hasan; J Khoury; R H Rosenwasser; P Jabbour
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-26       Impact factor: 3.825

10.  Analysis of Multiple Intracranial Aneurysms with Different Outcomes in the Same Patient After Endovascular Treatment.

Authors:  Linkai Jing; Jian Liu; Ying Zhang; Nikhil Paliwal; Hui Meng; Shengzhang Wang; Xinjian Yang
Journal:  World Neurosurg       Date:  2016-04-27       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.